Related Experiment Videos
Adverse cutaneous reactions to mood stabilizers.
Julia K Warnock1, David W Morris
1University of Oklahoma Health Sciences Center, Tulsa, Oklahoma 74135, USA. faye-biggs@ouhsc.edu
American Journal of Clinical Dermatology
|December 13, 2002
Summary
Mood stabilizers can cause severe skin reactions, including Stevens-Johnson syndrome. Patients should be informed of risks and seek immediate medical care for any suspected drug-induced skin reactions.
Area of Science:
- Dermatology
- Psychiatry
- Pharmacology
Background:
- Mood-stabilizing agents are frequently prescribed for psychiatric conditions.
- These medications carry a significant risk of severe and life-threatening adverse cutaneous drug reactions (ACDRs).
Purpose of the Study:
- To highlight the risk of severe ACDRs associated with mood-stabilizing agents.
- To inform healthcare providers and patients about potential cutaneous adverse effects and management strategies.
Main Methods:
- Review of literature on mood stabilizers and their associated cutaneous adverse reactions.
- Discussion of specific agents including carbamazepine, lithium carbonate, valproic acid, topiramate, lamotrigine, gabapentin, and oxcarbazepine.
Main Results:
- Mood stabilizers have the highest incidence of severe ACDRs among psychotropic medications.
- Exanthematous eruptions may indicate serious reactions like Stevens-Johnson syndrome or toxic epidermal necrolysis.
- Combination therapy may increase the risk of these reactions.
Conclusions:
- Patients must be educated about the potential benefits, risks, and adverse effects of mood stabilizers.
- Physicians should consider slow dose escalation and immediate discontinuation of the offending agent if severe ACDR is suspected.
- Prompt medical attention is crucial for patients experiencing suspected drug-induced skin reactions.